Atlas Trials

AI-EMERGE: Development and Validation of a Multi-analyte, Blood-based Colorectal Cancer Screening Test

Clinical trial NCT03688906 · COMPLETED

Trial details

NCT number
NCT03688906
Sponsor
Freenome Holdings Inc.
Status
COMPLETED
Study type
OBSERVATIONAL
Colo-rectal CancerCancer ColonCancer, RectumNeoplasms,ColorectalPolypsPolyp of ColonAdenomaAdenoma Colon
Start date
2018-01-12
Primary completion
2019-11-25
Enrollment
3275

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.